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People, like animals, tend to choose the variable option when given the
choice between a fixed and variable delay to reward where, in the variable
delay condition, some rewards are available immediately (Laura-Jean et al.
2019 Phil. Trans. R. Soc. B 374, 20180141. (doi:10.1098/rstb.2018.0141)).
This bias has been suggested to reflect evolutionary pressures resulting
from food scarcity in the past placing a premium on obtaining food quickly
that can win out against the risks of sometimes sustaining longer delays to
food. The psychologies mediating this effect may become maladaptive in the
developed world where food is readily available contributing, potentially, to
overeating and obesity. Here, we report our development of a novel touch-
screen task in mice allowing comparisons of the impact of food delay and
food magnitude across species. We show that mice exhibit the typical prefer-
ence, as shown by humans, for variable over fixed delays to rewards but no
preference when it comes to fixed versus variable reward amounts and
further show that this bias is sensitive to manipulations of the 5-HT2C recep-
tor, a key mediator of feeding and impulse control. We discuss the data in
terms of the utility of the task to model the psychologies and underlying
brain mechanisms impacting on feeding behaviours.
This article is part of the theme issue ‘Risk taking and impulsive behav-
iour: fundamental discoveries, theoretical perspectives and clinical
implications’.1. Background
People, like animals, can show ‘risk-seeking’ behaviour for food rewards, i.e.
preferring a variable interval schedule of food availability encompassing very
short delays interspersed with much longer delays, to a fixed delay that is
between the short and long extremes of the variable delay [1]. Although
humans, and other species, may be able to plan for famine and cache food
for these periods [2,3], finding food during these times of need may involve
increased risk for successful foraging. Thus, it has been suggested that risk-
seeking behaviour might reflect evolutionary pressures formed as a result of
food scarcity which has placed a premium on obtaining food immediately
against the risks of sometimes sustaining longer delays to the delivery of
food [4,5]. It has also been suggested that the psychologies mediating this
effect may become maladaptive in the developed world where food is readily
available contributing to overeating and obesity [6], and indeed the response
bias to variable delays has been shown to be sensitive to vulnerability factors
for weight gain that promote food-seeking behaviour (such as the presence of
food cues) [1,4,5].
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2Rogers et al. [7] have speculated that food scheduling of
the kind examined in the companion article by Stokes
et al. [1], and the impact of controlling variables such as the
presence of food cues, may overlap with the psychologies
and brain mechanisms underlying impulsive responding.
Individual differences in response control are mediated
predominately by circuits incorporating the prefrontal
cortex and striatum, modulated by forebrain neuromodu-
lators [8–10]. In the present context of biases in feeding
behaviour, the effects of manipulating the forebrain dopa-
minergic systems have been shown to influence preferences
for ‘risky’ variable delays over ‘less risky’ fixed delays for
food reward in rodents [7,11]. Less is known about other
neurotransmitter systems, though we have previously
shown in rats that variable delay preferences are also
diminished by the administration of the 5-HT1AR agonist
8-OH-DPAT [7], suggesting roles for both dopaminergic and
serotonergic mechanisms in food-scheduling behaviour [8].
One interesting candidate mechanism at the nexus of
feeding and response control is the 5-HT2C receptor
(5-HT2CR). The 5-HT2CR is distributed through the brain
with expression in the prefrontal cortex, hippocampus, stria-
tum, amygdala and the nuclei of the hypothalamus; regions
implicated in both response control [12,13] and eating-related
behaviours [14–16]. Deletion of 5-HT2CR in animal models is
associated with a number of behavioural phenotypes relevant
to feeding behaviours [17–19]. 5-HT2CR-null mice eat more
and become obese in adulthood [20,21] and consistent with
this finding selective 5-HT2CR agonists decrease appetite
[22,23]. Moreover, mouse models of Prader–Willi Syndrome
(PWS-IC), a disorder where a main abnormality is a pro-
found overeating [24], display hyperphagia and a reduced
effectiveness of the anorexic effects of 5-HT2CR agonism,
along with effects on cognition [25–27]. These effects are rel-
evant to 5-HT2CR functioning because the genetic lesion in
PWS-IC mice encompasses a deletion of SNORD115, a
small nucleolar RNA molecular involved in 5-HT2CR editing
and splicing [28], leading to less functional 5-HT2CRs in
PWS-IC mice [29]. In tandem with effects on eating, we and
others have also shown in both rat and mouse models that
manipulation of 5-HT2CR function impacts on risk sensitivity
and response control across a wide range of experimental set-
tings and tasks, including delayed reinforcement, 5-choice
serial reaction time task and stop signal reaction time task
[9,10,30,31].
In this paper, we report the development and behavioural
specification of an operant task for use in mice informed by
the food-scheduling models and methodologies described
by Stokes et al. [1]. We assayed risk tolerance using a novel
touchscreen platform that allowed an assessment of choices
between variable delays over fixed delays to reward and
also variable versus fixed amounts of reward. Reflecting
extensive evidence from foraging and operant contexts in
other species [4,5,32–34], we anticipated that mice would
demonstrate ‘risky’ preferences for the variable delay to
reward [32,33] and this is what we found. The preference
for choosing variable delays to reward was shown to be
robust following reversal of the stimulus/response contin-
gencies. By contrast, the mice exhibited no preference in
terms of fixed or variable reward amounts. We also examined
the effects of acute pharmacological manipulations of
5-HT2CR function on the preference for variable delays to
reward using the selective 5-HT2CR antagonist SB242084and 5-HT2CR agonist WAY161503. The pattern of drugs
effects was indicative of a high degree of specificity of
5-HT2CR action on risk-seeking behaviour for food rewards
and was also, we argue, consistent with a predominant
effect on the psychologies and brain mechanisms mediating
response control.2. Material and methods
(a) Subjects
A cohort of 44 male C57Bl/6OlaHsd mice (Envigo, UK), two
months old at the start of the experiment, was housed in groups
of four, in a vivarium (temperature: 21+ 28C, humidity 50%+
10) and a 12 L : 12 D cycle (lights on at 07.00). Food was available
ad libitum during the experiment. Following two weeks of habitu-
ation and handling, the mice were placed on a home cage water
restriction schedule to motivate the animals to work. Initially,
mice were restricted to 4 h access per day and once bodyweight
and drinking have stabilized, this was reduced to 2 h access per
day for the remainder of the experiment. Mice were monitored
throughout the experiment to check health and well-being, and
periodically, the mice were given 48 h of free access to water.
Animals were treated in accordance with the Animal (Scientific
Procedures) Act (United Kingdom, 1986), and experiments
performed under a UK project licence (PPL: 30/3135).
(b) Apparatus
All testing took place in two systems of four mouse touchscreen
operant chambers (Campden Cognition, UK, and see [35]), under
the control of custom written software (ABET, Campden Cogni-
tion, UK). Each touchscreen chamber was housed within a sound
attenuating box. The mouse enclosures were of a trapezoid
shape, with Perspex walls on three sides, and a metal grid
floor (figure 1a). The fourth side consisted of the touchscreen,
on which stimuli could be presented and to which the mice
were trained to respond. For the current task, involving choices
between variable and fixed delays to liquid rewards, the touchsc-
reen was occluded by a black Perspex mask with two 70 mm
square response apertures, 20 mm from the grid base of the
chamber and positioned equally across the width of the mask.
In the opposite side of the chamber, 5 mm from the grid base,
was a 20 mm square recess (25 mm deep) into which liquid
reward was delivered. Infrared beams were used to record
motor activity and an infrared CCTV system permitted
observation of the mice.
(c) Behavioural procedure
Once the mice were stabilized on the water restriction schedule,
they were habituated to the reward to be used in the experiment,
10% condensed milk solution, using standardized methods [30],
demonstrating greater than or equal to 80% preference for the
condensed milk solution versus water. The mice were then habi-
tuated to the touchscreen chambers in three daily 20 min sessions
in which the reward (22 ml) was delivered every 30 s. Following
this phase of training, the mice were next shaped to touch the
touchscreen to earn reward: single-stimulus training (SST). In
daily 20 min sessions of 60 trials, a single pattern stimulus per
trial was randomly presented to one of the stimuli locations on
the touchscreen, which remained on screen until touched.
Stimuli were randomly selected from the supplied image data-
base. Touching the stimulus initiated the delivery of 22 ml of
reward. Mice continued with SST until they completed greater
than 50 trials in a session for two consecutive days.
Once at SST criterion, the mice were moved to the main food-
scheduling task (FST) [1] protocol in which two stimuli were now
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Figure 1. Apparatus and task schedule for the fixed versus variable delay to reward (FST-D) or fixed versus variable reward amount (FST-R) food scheduling tasks.
(a) The apparatus used was a touchscreen chamber (Campden Cognition, UK), consisting of a trapezoid-shaped animal enclosure with a touch-sensitive screen
making up the larger wall. (b) A trial started with presentation of two stimuli to the screen, touching either one would lead to reward presentation following
a delay. Delay durations in the FST-D task or reward amount in the FST-R task, and for the probe manipulation sessions, were determined by the response made (see
figure 2a). Different pairs of stimuli were used for each phase of the task and for each new test within each phase (see electronic supplementary material, methods
figure S1 for stimuli pairs used).
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stimulus randomly determined per trial. Sessions were 20 min
or 60 trials long and were terminated by whichever criterion
was reached first. Responding to each stimulus would lead to a
reward, but under dissociable conditions (figure 2a). Thus, in
the fixed versus variable delay to reward version of the FST
(FST-D), 22 ml reward was delivered after the selection of either
the fixed 15 s delay choice or the variable 0 or 30 s delays (each
with a 0.5 probability of presentation) option. In the fixed
versus variable reward amount version of the FST (FST-R), the
delay to reward delivery was a constant 10 s for both choices,
but selection of the fixed option led to the delivery of 22 ml
of reward, whereas choosing the alternative could lead to
delivery of either 10 or 49 ml (each with a 0.5 probability of
presentation). The combination of delay durations and reward
quantities for each task was determined such that the coefficients
of reinforcement were equivalent [36,38] and that there were no
significant advantages in the amount or frequency of the reward
between the fixed and variable choices in each task (electronic
supplementary material, methods table S1). Stimuli associated
with each task choice (fixed or variable) were counter-balanced
between subjects.
All mice were assessed in both the FST-D and FST-R pro-
cedures, counter-balanced for testing order (figure 2b). There
were two test phases for each task, initial acquisition and rever-
sal, with a maximum of 20 sessions per phase. Transfer between
the phases was based on achieving performance criterion, set as
an arbitrary 75% preference for one of the choices in two succes-
sive sessions. Mice that failed to reach the preference criterion
within the 20 available sessions did not go through the reversal
procedure but instead went directly to the alternate task. For
those animals that reached the preference criterion during the
initial acquisition, the stimulus–reward contingencies were
reversed, such that the stimulus that was previously related to
the variable delay/reward now became the fixed delay/reward, and vice versa for the other stimulus. Following reversal,
these mice were given a further 20 sessions in each task to re-
establish stable responding. If they achieved the preference cri-
terion, then they were switched to the other task. Between the
two tasks, mice were placed back on the SST for three sessions.
On the completion of testing in the main FST-D and FST-R
tasks, we determined if the mice would exhibit a preference for
one of the stimulus/delay contingencies within a single session
FST-D. This was necessary for the acute drug challenge exper-
iments examining the effects of 5-HT2CR manipulation on the
expression of any choice preferences. Here, performance within
the single extended session (30 min/100 trials) was investigated
using novel stimuli but with the same delay durations and
reward amount as in the FST-D protocol (electronic supplemen-
tary material, methods figure S1).
(d) Pharmacological manipulations
Preferences for fixed or variable delays to reward were assessed
following 5-HT2CR manipulations with an acute single, extended
session/dose-modified FST-D protocol, with new combinations
of stimuli in each session (electronic supplementary material,
methods figure S1). The 5-HT2CR antagonist SB242084 HCl
(vehicle, 0.1, 1, 5 mg kg21) and the 5-HT2CR agonist
WAY161503 HCl (vehicle, 0.1, 1, 5 mg kg21; Tocris, UK) were
used as both show high selectivity (pKi ¼ 9.0 and pKi ¼ 7.2,
for the 5-HT2CR) [37,39]. Drugs were prepared fresh in physio-
logical saline each day, and SB242084 was administered 5 min
(subcutaneous, s.c.) and WAY161503 30 min (intraperitoneal,
i.p.) prior to the test. Dose ranges were selected based on pre-
vious studies in rats and mice using similar operant procedures
[9,30,40,41]. In particular, as 5-HT2CR agonism at higher doses
can produce anorexic effects and decreased locomotor activity
[9], we used a dose range of WAY161503 that included lower
doses to avoid general disruptions to task performance that
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Figure 2. Schematic of the experimental design and procedures. For both the fixed versus variable delay to reward (FST-D) and fixed versus variable reward amount
(FST-R) food-scheduling tasks, the subjects were presented with a choice between a fixed option and a variable option, which had two possible outcomes (1 : 1
probability of presentation). The combination of delay durations and reward quantities for each task (a) were determined such that the coefficients of reinforcement
were equivalent [36,37]. Mice were initially shaped to respond to the touchscreens with presentation of a single stimulus to the screen (SST), before proceeding
through the FST-R and FST-D tasks, with task order counter-balanced between subjects (b). Between the tasks, the mice were given three transition sessions of SST
to stabilize behaviour. Performance criteria for reversal: consistent/stable choice performance (.75% choice preference) for more than two sessions, maximum of 20
sessions per phase.
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ments. Each treatment was given using a Latin-square design,
with at least 4 days between each dose. Mice were not tested
between the drug administration sessions.
(e) Data analysis
Data were first assessed for normality. The main measure used to
gauge performance for the FST-D and FST-R tasks was the prefer-
ence for the variable versus fixed choice in each task, calculated as
a preference ratio: variable choice/(variable choice þ fixed
choice). Other measures included response latencies for each
choice, the time to collect the reward under each condition, the
number of completed trials and the number of sessions to reach
criterion in each phase of the experiment. Ratios were compared
to chance/no preference (0.5) using within subjects t-test or
equivalent non-parametric analysis such as Z, the Wilcoxen-
Signed Ranks statistic. The effects of SB242084 and WAY161503
were analysed by separate within-subject ANOVAs with a
within-subject factor of dose (vehicle, 0.1, 1, 5 mg kg21). If
significant, then post hoc pairwise comparisons were performed
using Bonferroni correction. Criterion level of significance was
set at the 0.05 level. All data are shown as mean+ s.e.m.3. Results
(a) FST-D and FST-R task acquisition and performance
Following habituation to the reinforcer and test apparatus,
the mice were first shaped to respond to the touchscreen by
the presentation of a single stimulus in one of the apertures,counter-balanced across trials. All of the mice demonstrated
good responding during this phase of training within
approximately eight sessions (electronic supplementary
material, results figure S1). In the first session of the FST-D,
all the mice showed no initial bias for either the fixed or
delay to reward choices (figure 3a, t43 ¼ 0.03, p ¼ 0.98). How-
ever, within approximately 10 sessions, the majority of mice
(34/44) demonstrated a marked preference for the choice
that led to a variable delay to reward, relative to chance
(figure 3a, Z43 ¼ 5.09, p ¼ 0.0001) and had exceeded the arbi-
trary criterion of 75% preference. It is important to note that
while some animals (10/44) did not manage to reach the 75%
preference criterion within the 20 sessions available, these
animals still showed above chance preference for the variable
delay option (figure 3a, Z43 ¼ 2.71, p ¼ 0.007). Thus, all the
animals tested in the FST-D task showed a significant prefer-
ence for the variable delay condition but there was a degree
of individual difference in developing the preference. To
test the extent to which it was the contingency between the
delays sustained to obtain the fixed amount of reward that
was controlling behaviour in the FST-D task, we reversed
the choice stimuli. Initially, on reversal behaviour was dis-
rupted with the mice showing no preference for either the
fixed or variable delay to rewards (figure 3b, t33 ¼ 0.44, p ¼
0.67) but this effect was short lived and all mice subjected
to reversal (34/34) regained the 75% preference criterion for
the variable delay choice within approximately 13 sessions,
showing a significant bias relative to chance (figure 3b,
t33 ¼ 24.11, p ¼ 0.0001).
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Figure 3. Preference for responding in the fixed versus variable delay to reward (FST-D) and fixed versus variable reward amount (FST-R) food-scheduling tasks. For
each task, mice were given a maximum of 20 sessions to reach an arbitrary 75% preference criterion. (a) In the FST-D, all mice initially showed no choice preference
but a majority (34/44) did reach the preference criterion within the 20 testing sessions available; the mice that did not reach the preference criterion (10/44) still
showed a significant above-chance preference. (b) The 34 mice that reached the 75% performance criterion in less than 20 sessions in the FST-D task were further
tested in reversal. After an initial disruption to behaviour, leading to the temporary abolition of the preference for the variable delay condition, this preference was
rapidly re-established post-reversal with all of the mice reaching the 75% preference criterion within 20 sessions. (c) In the FST-R task, however, the initial lack of
preference for fixed or variable amounts of reward persisted throughout the 20 test sessions available. This was the case for the large majority (42/44) of the
animals but two animals did show a preference for the variable amount of reward choice and indeed reached the arbitrary 75% preference criterion, the data
for these two mice have been included for completeness. Data show mean+ s.e.m. N values for each condition are shown within the individual bar charts.
*** denotes p, 0.001 for choice preference in comparison to chance (no preference) performance.
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374:20180144A different pattern of effects was apparent when the mice
were tested in the FST-R task. Again, at the beginning of test-
ing, the mice showed no preference for either the fixed or
variable reward amount choices (figure 3c, t43 ¼ 0.36, p ¼
0.72) but unlike in the FST-D task, this lack of preference per-
sisted throughout the 20 test sessions available, such that for
the large majority of mice (42/44), there was no significant
difference in choice preference relative to chance at session
20 (figure 3c, t43 ¼ 0.97, p ¼ 0.34). Two mice out of the total
of 44 did show a preference for the variable amount choice,
reaching the arbitrary 75% preference criterion; the data for
these mice have been included in figure 3 for completeness.
The inability to clearly discriminate between the fixed and
variable reward amount choices led to significant reductions
in the completed trials and slowing in choice times between
the first and last sessions of the acquisition phase of FST-R
testing (electronic supplementary material, results figure S2).
The order of training with the two tasks (FST-D and FST-
R), which was counter-balanced between subjects, was with-
out effects on performance and all mice still demonstrated
strong preferences for the variable delay choice in the
FST-D whether this task came first or second in the run
order. Furthermore, as shown in the electronic supplemen-
tary material (results figure S3), the performance of the
FST-D task was associated with a high degree of stimulus
control and motivation as indicated by the number of trials
committed per session, the quicker response times and time
taken to collect the reward. The main difference in these ancil-
lary measures was an expected reduction in choice times as
training progressed which was manifest independently of
response choice. There were also no systematic differences
in ancillary behavioural measures between those animals
that reached the 75% preference criterion and those that didnot, and pre- and post-reversal stable performance. Taken
together, the pattern of results in choice preference from the
two tasks, fixed and variable delay to reward (FST-D) and
fixed and variable reward amount (FST-R) were consistent
with previous findings in other species [1,4,5,33].(b) Drug manipulations
Prior to the drug challenges, we confirmed that the mice
could learn to discriminate between the fixed and variable
delays to reward in the FST-D task using new stimuli in a
single session protocol. In this part of the study, we confined
testing to the 34 mice that had shown robust preferences for
variable delay to reward in the main FST-D task as indexed
by reaching the 75% preference criterion within the 20 avail-
able sessions. Under the single session protocol, the mice
showed a preference of 0.67+ 0.02 for the variable delay to
reward choice over the fixed delay to reward. However,
this choice preference, though significantly above chance
(t33 ¼ 7.88, p ¼ 0.0001) was smaller than the typical 0.8–0.9
preference ratios seen in the main FST-D task with multiple
training sessions. The relative reduction in the choice prefer-
ence in the single session FST-D protocol was unsurprising,
because the mice had more limited opportunity to manifest
a preference with novel stimuli/reward combinations, and
consequently fewer mice (13/34) reached a 75% preference
criterion, but it was deemed sufficient for the effects of
drugs to be analysed.
The effects of the 5-HT2CR antagonist SB242084 and 5-
HT2CR agonist WAY161503 compared to administration of
0.9% vehicle on choices for fixed and variable delay to
reward (FST-D) are shown in figure 4. Importantly, following
administration of vehicle alone, the preference for the
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Figure 4. Effects of 5-HT2CR antagonism and agonism on the preference for variable or fixed delays to reward. Data showing the effects of increasing doses of (a)
the selective 5-HT2CR antagonist SB212084 and (b) selective 5-HT2CR agonist WAY161503 on choice preference for fixed or variable delays to reward compared to
vehicle (0.9% saline). Choice preferences were assessed following 5-HT2CR manipulations with an acute single, extended session/dose-modified FST-D protocol, with
new combinations of stimuli for each drug dose. SB212084 was administered s.c. and WAY161503 i.p. Data are mean+ s.e., N ¼ 34. * denotes p, 0.05 for
comparison between vehicle and drug dose, and ### and # denote p, 0.001 and p, 0.05 for comparison to chance (no preference) performance.
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(t33 ¼ 4.23, p ¼ 0.0001) at 0.62+ 0.03, indicating minimal
effects of the injections per se. The 5-HT2CR antagonist
SB242084 increased preference for the variable delay choice,
relative to vehicle, at the lowest 0.1 mg kg21 dose only
(figure 4a, main effect of dose, F2.3,77.4 ¼ 3.91, p ¼ 0.02; p ¼
0.02 for post hoc comparison between 0.01 mg kg21 dose
and vehicle, p. 0.05 for other doses relative to vehicle) but
at all doses the preference for the variable delay to reward
was maintained above chance ( p, 0.001 for 0.1 and
1 mg kg21 and p, 0.05 for 5 mg kg21). The effects of
SB242084 were specific to choice preference and were not
associated with any drug-induced effects on general features
of behaviour across all doses of the drug, such as numbers of
trials, response times and the latency to collect the reward
(electronic supplementary material, results figure S4). Agon-
ism of the 5-HT2CR with WAY161503 was associated with a
different pattern of effects, not enhancing the preference for
the variable delay choice relative to vehicle-treated animals
(which showed a significant above-chance preference for
variable delays) but instead at all doses tending to reduce
the preference to chance levels (figure 4b, main effect of
dose, F2.8,94.09 ¼ 2.17, p ¼ 0.09). The two lowest doses of
WAY161503 were without effects on ancillary behavioural
measures but the highest, 5 mg kg21, dose did lead to signifi-
cant reductions in the number of trials completed, choice
latency and the time taken to collect the reward (electronic
supplementary material, results figure S4) which may be
due to specific effects, such as anorexic effects or reduced
locomotor activity at this dose of drug.4. Discussion
Here, we describe a touchscreen-based model of the concur-
rent choice procedure based on Stokes et al. [1] FST to
investigate risk tolerance in the context of feeding behaviour
in mice. To our knowledge, this is the first demonstration
using an operant approach that this species, like humans[1] and birds [4,5,32], shows an inherent preference for
‘risky’ variable delays over fixed delay schedules [4]. Impor-
tantly, the bias towards variable delays was sufficiently
strong and flexible to be still present following reversal of
the stimuli/delay contingencies, indicating the robustness
of the preference. We also describe novel pharmacological
data implicating an important role for 5-HT2CR mechanisms
in mediating risk tolerance towards variable delays in the
delivery of rewarding foodstuffs. Together, our findings indi-
cate the utility of the murine touchscreen model system for
making valid cross-species comparisons [31,35] and open
up the area to the wide range of genetic models available
in the mouse.
Consistent with previous data in other animal species, the
mice displayed different choice biases depending on the food
availability schedules; as noted above, exhibiting risk-seeking
behaviour in the context of delays to rewards but no discern-
ible preference between fixed or variable reward amounts
[4,34]. To ascertain the controlling variables in the task, we
carried out a probe test in which we reversed the stimulus/
reward-delay contingencies in the fixed or variable delay to
reward food-scheduling task (FST-D). Following a period of
adjustment, the animals showed the same strong choice pre-
ference for variable delays as before the reversal, indicating
that the main variable controlling performance in the task
was the impact of the variable/fixed delays. Overall, the
data confirmed that the mice were able to learn the task con-
tingencies with a high degree of stimulus control as indicated
by the consistent numbers of trials committed per session,
and the rapid response latencies and time taken to collect
the reward.
Systemic administration of SB242084, a selective 5-HT2CR
antagonist, increased further the baseline (non-drugged) pro-
pensity of the mice to choose the variable delay option versus
a fixed delay to reward option in the FST-D task, whereas
systemic WAY161503, a selective agonist, tended to reduce
the preference for the variable delay to reward option. In
order to assess the effects of the drugs on the development
and expression of choice preferences in the FST-D task,
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stimuli/delay combinations. As noted previously, while this
modified protocol did still reveal a significant preference for
variable delays in the mice, the extent of the preference was
less than that seen in the main multi-session protocol. This
is of potential relevance to the interpretation of the drug
effects since, while the degree of preference shown by the
vehicle-administered animals allowed an increase in prefer-
ence for the variable delay choice to be seen following
treatment with SB242084, it may have compressed the
range available to detect the decrease in preference observed
with WAY161503. However, this effect was not a true floor
effect because WAY161503 did not elicit a switch over to
the fixed delay option which the animals were perfectly
free to do but instead reduced responding to chance. None-
theless, some degree of caution should be attached to these
data and it would be interesting, in future work, to also
assess the effects of 5-HT2CR antagonism and agonism at per-
formance as well as during the acquisition of choice
preferences. These new data on 5-HT2CR mechanisms add
to the previous finding that administration of the 5-HT1AR
agonist, 8-OH-DPAT, dose-dependently diminished selec-
tions of variable delay to reward over fixed delay to reward
options [7] at performance and extend the influence of the
serotonin system on risk tolerance in the context of feeding.
Our observation that SB242084 and WAY161503 produce
opposing effects upon the preference for variable over fixed
delay schedules could potentially reflect actions within two
basic functional domains of the 5-HT2CR system: effects on
appetite and drive to eat per se and/or changes in delay dis-
counting, response control functions. As noted earlier, 5-
HT2CRs have well established roles in appetite and satiety;
in particular, 5-HT2CR agonism is known to cause anorexic
responses in rodents. However, without discounting them
totally it is difficult to envisage that drug effects on feeding
per se were a main driver of the behaviour because such gen-
eral effects cannot easily be accommodated with the pattern
of results on choice preferences. Moreover, there were no
indications from ancillary aspects of behaviour, such as
response latencies and the latency to collect reward, for
effects related to changes in appetite, satiety or hedonic
characteristics of the food reward at any of the doses of
SB242084 used. This was also the case for the two lower
doses of WAY161503. However, as noted in the Results, the
highest 5 mg kg21 dose did lead to significant reductions in
the number of trials completed, choice latency and the timetaken to collect the reward, which may be related to the pre-
viously reported effects on motor activity patterns [9]. Here,
the possibility of known anorexic effects of WAY161503 [40]
influencing choice preferences at this dose might be
entertained.
On the other hand, the opposing effects of agonist and
antagonists of 5-HT2CR on choice preference may reflect
some modulation of impulse control. These could arise in
two ways. First, preferences for variable over fixed delays
schedules have been hypothesized to reflect the greater
summed value of immediate and discounted rewards deliv-
ered following longer delays compared with the single
moderately discounted rewards delivered following inter-
mediate rewards ([5,32–34] but see [38]). From this view,
the opposing effects of SB242084 and WAY161503 adminis-
tration upon preferences for variable over fixed delay to
reward schedules could represent changes in the values of
discounted rewards. A second interpretation of the drug
effects is related to data showing that the 5-HT2CR antagonist,
SB242084, can increase premature responding in operant set-
tings [9,10]. Possibly therefore, especially under conditions of
mild water deprivation, the subjects of our experiment
acquired preferences for the variable delay schedule as the
pre-potent option that offered the possibility of immediate
liquid rewards but at the risk of longer delays than the inter-
mediate delays offered by the fixed delay to reward schedule.
Under these conditions, administration of SB242084 could
have released or enhanced its selection while administration
of the agonist WAY161503 reduced its selection as a form of
improved response control. Dissociating which of the mech-
anisms may be controlling behaviour, or whether the
resultant effects are a combination of the two ideas, would
take further study.
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